GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Cross Corp (XKRX:006280) » Definitions » 5-Year EBITDA Growth Rate

Green Cross (XKRX:006280) 5-Year EBITDA Growth Rate : -2.00% (As of Dec. 2024)


View and export this data going back to 1989. Start your Free Trial

What is Green Cross 5-Year EBITDA Growth Rate?

Green Cross's EBITDA per Share for the three months ended in Dec. 2024 was ₩-1,099.93.

During the past 12 months, Green Cross's average EBITDA Per Share Growth Rate was 4.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -30.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -2.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Green Cross was 45.30% per year. The lowest was -30.60% per year. And the median was 1.00% per year.


Competitive Comparison of Green Cross's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Green Cross's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Green Cross's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Cross's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Green Cross's 5-Year EBITDA Growth Rate falls into.


;
;

Green Cross 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Green Cross  (XKRX:006280) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Green Cross 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Green Cross's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Cross Business Description

Traded in Other Exchanges
N/A
Address
303 Bojeong-Dong, Giheung-Gu, Yongin, Gyeonggi, KOR, 449-070
Green Cross Corp is one of the global leaders in the healthcare sector. The Montreal-based biopharmaceutical company primarily develops intravenous immunoglobulin (IVIG), a key therapeutic solution for the treatment of patients with infectious and immune diseases, and albumin, used as a blood-volumizing agent and in the treatment of burns. Currently, the company has a global presence through its association with various subsidiaries.

Green Cross Headlines

No Headlines